Business:
Synthetic Biology to Create Therapeutic Stem Cells
About:
GC Therapeutics is using synthetic biology to program patients' cells into any cell type. Engineering the identity of a cell has a lot of potential as a new therapeutic modality as well as for cell therapies, transplants and testing new drugs. GCTx’s approach involves reprogramming patient-derived stem cells to make various cell types by discovering novel cell-differentiation recipes. The aim is to make this approach both efficient and scalable by dictating cell fates in a single step. In addition, GCTx is developing SuperCellsTM by tailoring cells for specific diseases.